Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.

[1]  A. D'Amico,et al.  Neoplasms of the Prostate , 2003 .

[2]  Bernhard O. Palsson,et al.  Cancer cell lines , 1999 .

[3]  W. Fiers,et al.  Differential activation of phospholipases during necrosis or apoptosis: A comparative study using tumor necrosis factor and anti‐Fas antibodies , 1998, Journal of cellular biochemistry.

[4]  A. Newland,et al.  Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. , 1998, Journal of immunology.

[5]  L. Marshall,et al.  Cytosolic 85-kDa Phospholipase A2-mediated Release of Arachidonic Acid Is Critical for Proliferation of Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[6]  H. Kamohara,et al.  Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer , 1997, International journal of cancer.

[7]  M. Lazdunski,et al.  Cloning, Chromosomal Mapping, and Expression of a Novel Human Secretory Phospholipase A2 * , 1997, The Journal of Biological Chemistry.

[8]  David G. Bostwick,et al.  Urologic Surgical Pathology , 1997 .

[9]  F. Faas,et al.  Increased phospholipid fatty acid remodeling in human and rat prostatic adenocarcinoma tissues. , 1996, The Journal of urology.

[10]  S. Nagata,et al.  Different apoptotic pathways mediated by Fas and the tumor-necrosis-factor receptor. Cytosolic phospholipase A2 is not involved in Fas-mediated apoptosis. , 1996, European journal of biochemistry.

[11]  J. D. Clark,et al.  Cytosolic phospholipase A2. , 1995, Journal of lipid mediators and cell signalling.

[12]  D. Shepro,et al.  Arachidonic acid metabolites in bFGF-, PDGF-, and serum-stimulated vascular cell growth. , 1994, Experimental cell research.

[13]  S. McClinton,et al.  Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitors , 1994, International journal of cancer.

[14]  T. Nevalainen,et al.  Secretion of group 2 phospholipase A2 by lacrimal glands. , 1994, Investigative ophthalmology & visual science.

[15]  T. Nevalainen,et al.  Synovial‐type (group II) phospholipase A2 human seminal plasma , 2009, Andrologia.

[16]  M. Ogawa,et al.  Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa. , 1993, British Journal of Cancer.

[17]  J. Yamashita,et al.  Increased expression of membrane‐associated phospholipase A2 shows malignant potential of human breast cancer cells , 1993, Cancer.

[18]  R. Mayer,et al.  New insights on mammalian phospholipase A2(s); comparison of arachidonoyl‐selective and ‐nonselective enzymes , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  A. Schmitz,et al.  Synovial type (group II) phospholipase A2 in cartilage. , 1993, The Journal of rheumatology.

[20]  M. Ogawa,et al.  Immunohistochemical localization of group II phospholipase A2 in human pancreatic carcinomas , 1993, International journal of pancreatology : official journal of the International Association of Pancreatology.

[21]  Kramer Rm.  Structure, function and regulation of mammalian phospholipases A2. , 1993 .

[22]  R. Kramer.  Structure, function and regulation of mammalian phospholipases A2. , 1993, Advances in second messenger and phosphoprotein research.

[23]  S. McClinton,et al.  Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease. , 1991, British Journal of Cancer.

[24]  S. Ikei,et al.  Elevation of serum group II phospholipase A2 in patients with cancers of digestive organs. , 1991, Research communications in chemical pathology and pharmacology.

[25]  V. Fafeur,et al.  Signal transduction by bFGF, but not TGFβ1, involves arachidonic acid metabolism in endothelial cells , 1991, Journal of cellular physiology.

[26]  R. Dahiya,et al.  Alterations in sphingomyelin and fatty acids in human benign prostatic hyperplasia and prostatic cancer. , 1991, Biomedica biochimica acta.

[27]  D. Rose,et al.  Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines , 1991, The Prostate.

[28]  D. Rose,et al.  Effects of dietary menhaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. , 1988, Carcinogenesis.

[29]  M. Rubenstein,et al.  Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. , 1985, American journal of reproductive immunology and microbiology : AJRIM.